Literature DB >> 12181232

Cardiovascular and coronary risk estimation in hypertension management.

Erica J Wallis1, Lawrence E Ramsay, Peter R Jackson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181232      PMCID: PMC1767334          DOI: 10.1136/heart.88.3.306

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  17 in total

1.  Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.

Authors:  E J Wallis; L E Ramsay; I Ul Haq; P Ghahramani; P R Jackson; K Rowland-Yeo; W W Yeo
Journal:  BMJ       Date:  2000-03-11

Review 2.  Mild hypertension: treat patients, not populations.

Authors:  L E Ramsay
Journal:  J Hypertens       Date:  1985-10       Impact factor: 4.844

3.  The number needed to treat: a clinically useful measure of treatment effect.

Authors:  R J Cook; D L Sackett
Journal:  BMJ       Date:  1995-02-18

4.  The potential effect of blood pressure reduction on cardiovascular disease. A cautionary note.

Authors:  S Madhavan; M H Alderman
Journal:  Arch Intern Med       Date:  1981-11

5.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

6.  British Hypertension Society guidelines for hypertension management 1999: summary.

Authors:  L E Ramsay; B Williams; G D Johnston; G A MacGregor; L Poston; J F Potter; N R Poulter; G Russell
Journal:  BMJ       Date:  1999-09-04

7.  Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validation.

Authors:  E J Wallis; L E Ramsay; I U Haq; P Ghahramani; P R Jackson
Journal:  J Hypertens       Date:  2001-04       Impact factor: 4.844

8.  Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension.

Authors:  A W Hoes; D E Grobbee; J Lubsen
Journal:  J Hypertens       Date:  1995-07       Impact factor: 4.844

9.  Cardiovascular disease risk profiles.

Authors:  K M Anderson; P M Odell; P W Wilson; W B Kannel
Journal:  Am Heart J       Date:  1991-01       Impact factor: 4.749

10.  Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?

Authors:  S A Grover; L Coupal; X P Hu
Journal:  JAMA       Date:  1995-09-13       Impact factor: 56.272

View more
  5 in total

1.  Low Subjective Cardiovascular Disease Risk Perceptions among Hypertensive Patients in Addis Ababa, Ethiopia.

Authors:  Daniel Mengistu Bekele; Dejuma Yadeta Goshu; Alemayehu Worku Yalew; Melinda K Higgins; Rebecca A Gary
Journal:  Integr Blood Press Control       Date:  2022-08-05

2.  The effect of how outcomes are framed on decisions about whether to take antihypertensive medication: a randomized trial.

Authors:  Cheryl L L Carling; Doris Tove Kristoffersen; Andrew D Oxman; Signe Flottorp; Atle Fretheim; Holger J Schünemann; Elie A Akl; Jeph Herrin; Thomas D MacKenzie; Victor M Montori
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

3.  Prevalence of hypertension among office workers in a multi-national company in the Niger-Delta with the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines.

Authors:  Sandra N Ofori; Jide Obosi
Journal:  Prev Med Rep       Date:  2019-05-18

4.  A Role of Socioeconomic Status in Cognitive Impairment Among Older Adults in Macau: A Decomposition Approach.

Authors:  Zhuo Zhang; Yonghua Zhao; Ying Bian
Journal:  Front Aging Neurosci       Date:  2022-02-08       Impact factor: 5.750

5.  Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.

Authors:  Rohan Khera; Yuan Lu; Jiapeng Lu; Anshul Saxena; Khurram Nasir; Lixin Jiang; Harlan M Krumholz
Journal:  BMJ       Date:  2018-07-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.